Skip to main content

Table 1 Sociodemographic, clinical characteristics and HPV profile of cases by histological grade and age group (Guadeloupe, 2014–2016)

From: Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe

  Overall CIN 2/3 grades Invasive cancers p < 40 years 41–50 years > 50 years p
n = 213 n = 184 n = 29   n = 111 n = 56 n = 46  
Year of diagnosis, n(%)     0.53     0.25
 2014 98 (46) 82 (45) 16 (55)   44 (40) 27 (48) 27 (59)  
 2015 50 (23) 45 (24) 5 (17)   29 (26) 14 (25) 7 (15)  
 2016 65 (31) 57 (31) 8 (28)   38 (34) 15 (27) 12 (26)  
HPV status, n(%)     0.67     0.33
 HPV- 12 (6) 10 (5) 2 (7)   6 (5) 5 (9) 1 (2)  
 HPV+ 201 (94) 174 (95) 27 (93)   105 (95) 51 (91) 45 (98)  
  n = 188 n = 162 n = 26   n = 97 n = 48 n = 43  
Profile of infectiona, n(%)     0.002     0.99
 1 virus 34 (18.1) 32 (19.7) 2 (7.7)   18 (18.6) 9 (18.7) 7 (16.3)  
 2 to 3 virus 66 (35.1) 49 (30.2) 17 (65.4)   33 (34.0) 17 (35.4) 16 (37.2)  
  >  3 virus 88 (46.8) 81 (50.0) 7 (26.9)   46 (47.4) 22 (45.8) 20 (46.5)  
HPV oncogenicity riska, n(%)
 High-risk 183 (91) 157 (91) 26 (93) 0.77 93 (84) 48 (86) 42 (91) 0.48
 Probable High risk 104 (52) 90 (52) 14 (50) 0.95 52 (47) 27 (48) 25 (54) 0.69
 Low risk and others 101 (51) 84 (49) 17 (61) 0.92 52 (47) 24 (43) 25 (54) 0.50
HR-HPV in combinationa, n(%)     0.6     0.7
No HR 5 (2.7) 5 (3.1) 0   4 (4.1) 0 1 (2.3)  
1 HR 58 (30.8) 48 (29.6) 10 (38.5)   28 (28.9) 17 (35.4) 13 (30.2)  
2–3 HR 91 (48.4) 80 (49.4) 11 (42.3)   45 (46.4) 23 (47.9) 23 (53.5)  
> 3 HR 34 (18.1) 29 (17.9) 5 (19.2)   20 (20.6) 8 (16.7) 6 (13.9)  
  1. a Proportions are calculated after excluding positive cases with missing data for genotypes and negative cases